A feasibility study using three-dimensional conformal boost technique in locally advanced carcinoma of the nasopharynx

Eon Kim Gwi Eon Kim, J. Lim, Chul Park Hee Chul Park, Chang Keum Ki Chang Keum, Yongbae Kim, Rock Moon Sun Rock Moon, Geol Lee Chang Geol Lee, Jinsil Seong, Chang-Ok Suh

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

To investigate the feasibility and efficacy of dose escalation using three-dimensional (3-D) conformal boost technique, 21 patients with stage III or IV nasopharyngeal cancer were enrolled in a prospective protocol. All patients with node metastases initially received external radiotherapy by conventional technique up to 70.2 Gy, followed by 3-D conformal radiotherapy (3-D CRT) to the boost part up to 79.2 Gy with 9 Gy increments (daily fraction of 1.8 Gy for 5 days). A modified technique with the same dose escalation of 9 Gy using 3-D CRT was applied to 7 patients without node metastases, who were treated by conventional technique up to 54 Gy, followed by 3-D CRT to boost up to a basic dose of 70.2 Gy, and then finally with dose escalation of 9 Gy. The protocol was relatively well tolerated by the majority of patients. Acute complications during the dose escalation schedule was low, with rare occurrences of grade 3 or 4 toxicity. Although late radiation-induced complications also appeared limited, 1 patient developed a temporal lobe necrosis and 2 patients suffered from sensory-neural hearing loss. There were no radiation-induced fatal complications. At a median follow-up of 48 months, only 3 patients experienced local failure and 2 patients developed distant metastases. The 5-year overall actuarial survival rate and recurrence-free survival rate for all patients were 68% and 85%, respectively. On the basis of acceptable morbidity and encouraging treatment results, we conclude that the dose escalation in 9 Gy increments using a 3-D conformal boost technique is relatively safe and efficacious, enough to be used routinely for locally advanced nasopharyngeal cancers.

Original languageEnglish
Pages (from-to)582-587
Number of pages6
JournalActa Oncologica
Volume40
Issue number5
DOIs
Publication statusPublished - 2001 Oct 10

Fingerprint

Nasopharynx
Feasibility Studies
Carcinoma
Conformal Radiotherapy
Nasopharyngeal Neoplasms
Neoplasm Metastasis
Survival Rate
Radiation
Temporal Lobe
Hearing Loss
Appointments and Schedules
Necrosis
Radiotherapy
Morbidity
Recurrence

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Gwi Eon Kim, Eon Kim ; Lim, J. ; Hee Chul Park, Chul Park ; Ki Chang Keum, Chang Keum ; Kim, Yongbae ; Sun Rock Moon, Rock Moon ; Chang Geol Lee, Geol Lee ; Seong, Jinsil ; Suh, Chang-Ok. / A feasibility study using three-dimensional conformal boost technique in locally advanced carcinoma of the nasopharynx. In: Acta Oncologica. 2001 ; Vol. 40, No. 5. pp. 582-587.
@article{3563956d0d5f4a2d947e81ebb5ac3dc2,
title = "A feasibility study using three-dimensional conformal boost technique in locally advanced carcinoma of the nasopharynx",
abstract = "To investigate the feasibility and efficacy of dose escalation using three-dimensional (3-D) conformal boost technique, 21 patients with stage III or IV nasopharyngeal cancer were enrolled in a prospective protocol. All patients with node metastases initially received external radiotherapy by conventional technique up to 70.2 Gy, followed by 3-D conformal radiotherapy (3-D CRT) to the boost part up to 79.2 Gy with 9 Gy increments (daily fraction of 1.8 Gy for 5 days). A modified technique with the same dose escalation of 9 Gy using 3-D CRT was applied to 7 patients without node metastases, who were treated by conventional technique up to 54 Gy, followed by 3-D CRT to boost up to a basic dose of 70.2 Gy, and then finally with dose escalation of 9 Gy. The protocol was relatively well tolerated by the majority of patients. Acute complications during the dose escalation schedule was low, with rare occurrences of grade 3 or 4 toxicity. Although late radiation-induced complications also appeared limited, 1 patient developed a temporal lobe necrosis and 2 patients suffered from sensory-neural hearing loss. There were no radiation-induced fatal complications. At a median follow-up of 48 months, only 3 patients experienced local failure and 2 patients developed distant metastases. The 5-year overall actuarial survival rate and recurrence-free survival rate for all patients were 68{\%} and 85{\%}, respectively. On the basis of acceptable morbidity and encouraging treatment results, we conclude that the dose escalation in 9 Gy increments using a 3-D conformal boost technique is relatively safe and efficacious, enough to be used routinely for locally advanced nasopharyngeal cancers.",
author = "{Gwi Eon Kim}, {Eon Kim} and J. Lim and {Hee Chul Park}, {Chul Park} and {Ki Chang Keum}, {Chang Keum} and Yongbae Kim and {Sun Rock Moon}, {Rock Moon} and {Chang Geol Lee}, {Geol Lee} and Jinsil Seong and Chang-Ok Suh",
year = "2001",
month = "10",
day = "10",
doi = "10.1080/028418601750444114",
language = "English",
volume = "40",
pages = "582--587",
journal = "Acta Oncologica",
issn = "0284-186X",
publisher = "Informa Healthcare",
number = "5",

}

Gwi Eon Kim, EK, Lim, J, Hee Chul Park, CP, Ki Chang Keum, CK, Kim, Y, Sun Rock Moon, RM, Chang Geol Lee, GL, Seong, J & Suh, C-O 2001, 'A feasibility study using three-dimensional conformal boost technique in locally advanced carcinoma of the nasopharynx', Acta Oncologica, vol. 40, no. 5, pp. 582-587. https://doi.org/10.1080/028418601750444114

A feasibility study using three-dimensional conformal boost technique in locally advanced carcinoma of the nasopharynx. / Gwi Eon Kim, Eon Kim; Lim, J.; Hee Chul Park, Chul Park; Ki Chang Keum, Chang Keum; Kim, Yongbae; Sun Rock Moon, Rock Moon; Chang Geol Lee, Geol Lee; Seong, Jinsil; Suh, Chang-Ok.

In: Acta Oncologica, Vol. 40, No. 5, 10.10.2001, p. 582-587.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A feasibility study using three-dimensional conformal boost technique in locally advanced carcinoma of the nasopharynx

AU - Gwi Eon Kim, Eon Kim

AU - Lim, J.

AU - Hee Chul Park, Chul Park

AU - Ki Chang Keum, Chang Keum

AU - Kim, Yongbae

AU - Sun Rock Moon, Rock Moon

AU - Chang Geol Lee, Geol Lee

AU - Seong, Jinsil

AU - Suh, Chang-Ok

PY - 2001/10/10

Y1 - 2001/10/10

N2 - To investigate the feasibility and efficacy of dose escalation using three-dimensional (3-D) conformal boost technique, 21 patients with stage III or IV nasopharyngeal cancer were enrolled in a prospective protocol. All patients with node metastases initially received external radiotherapy by conventional technique up to 70.2 Gy, followed by 3-D conformal radiotherapy (3-D CRT) to the boost part up to 79.2 Gy with 9 Gy increments (daily fraction of 1.8 Gy for 5 days). A modified technique with the same dose escalation of 9 Gy using 3-D CRT was applied to 7 patients without node metastases, who were treated by conventional technique up to 54 Gy, followed by 3-D CRT to boost up to a basic dose of 70.2 Gy, and then finally with dose escalation of 9 Gy. The protocol was relatively well tolerated by the majority of patients. Acute complications during the dose escalation schedule was low, with rare occurrences of grade 3 or 4 toxicity. Although late radiation-induced complications also appeared limited, 1 patient developed a temporal lobe necrosis and 2 patients suffered from sensory-neural hearing loss. There were no radiation-induced fatal complications. At a median follow-up of 48 months, only 3 patients experienced local failure and 2 patients developed distant metastases. The 5-year overall actuarial survival rate and recurrence-free survival rate for all patients were 68% and 85%, respectively. On the basis of acceptable morbidity and encouraging treatment results, we conclude that the dose escalation in 9 Gy increments using a 3-D conformal boost technique is relatively safe and efficacious, enough to be used routinely for locally advanced nasopharyngeal cancers.

AB - To investigate the feasibility and efficacy of dose escalation using three-dimensional (3-D) conformal boost technique, 21 patients with stage III or IV nasopharyngeal cancer were enrolled in a prospective protocol. All patients with node metastases initially received external radiotherapy by conventional technique up to 70.2 Gy, followed by 3-D conformal radiotherapy (3-D CRT) to the boost part up to 79.2 Gy with 9 Gy increments (daily fraction of 1.8 Gy for 5 days). A modified technique with the same dose escalation of 9 Gy using 3-D CRT was applied to 7 patients without node metastases, who were treated by conventional technique up to 54 Gy, followed by 3-D CRT to boost up to a basic dose of 70.2 Gy, and then finally with dose escalation of 9 Gy. The protocol was relatively well tolerated by the majority of patients. Acute complications during the dose escalation schedule was low, with rare occurrences of grade 3 or 4 toxicity. Although late radiation-induced complications also appeared limited, 1 patient developed a temporal lobe necrosis and 2 patients suffered from sensory-neural hearing loss. There were no radiation-induced fatal complications. At a median follow-up of 48 months, only 3 patients experienced local failure and 2 patients developed distant metastases. The 5-year overall actuarial survival rate and recurrence-free survival rate for all patients were 68% and 85%, respectively. On the basis of acceptable morbidity and encouraging treatment results, we conclude that the dose escalation in 9 Gy increments using a 3-D conformal boost technique is relatively safe and efficacious, enough to be used routinely for locally advanced nasopharyngeal cancers.

UR - http://www.scopus.com/inward/record.url?scp=0034789092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034789092&partnerID=8YFLogxK

U2 - 10.1080/028418601750444114

DO - 10.1080/028418601750444114

M3 - Article

C2 - 11669329

AN - SCOPUS:0034789092

VL - 40

SP - 582

EP - 587

JO - Acta Oncologica

JF - Acta Oncologica

SN - 0284-186X

IS - 5

ER -